FY2028 EPS Estimates for Senseonics Boosted by HC Wainwright

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - Equities research analysts at HC Wainwright lifted their FY2028 earnings per share estimates for shares of Senseonics in a research report issued on Monday, July 14th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings per share of $0.00 for the year, up from their prior forecast of ($0.01). HC Wainwright has a "Buy" rating and a $1.40 price objective on the stock. The consensus estimate for Senseonics' current full-year earnings is ($0.14) per share.

Several other analysts have also recently weighed in on the stock. Mizuho assumed coverage on shares of Senseonics in a research note on Thursday, April 10th. They set an "outperform" rating and a $2.00 price objective on the stock. Wall Street Zen raised Senseonics to a "sell" rating in a research note on Monday, May 12th.

Senseonics Price Performance

NYSE:SENS opened at $0.49 on Tuesday. The company has a market capitalization of $322.46 million, a price-to-earnings ratio of -3.79 and a beta of 0.92. The company has a 50-day moving average of $0.53 and a 200-day moving average of $0.68. Senseonics has a 52 week low of $0.25 and a 52 week high of $1.40. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Institutional Trading of Senseonics

A number of institutional investors have recently modified their holdings of SENS. First Light Asset Management LLC bought a new stake in Senseonics during the 4th quarter worth about $3,366,000. Geode Capital Management LLC increased its position in shares of Senseonics by 9.7% in the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company's stock valued at $3,354,000 after acquiring an additional 566,704 shares during the last quarter. Jane Street Group LLC raised its holdings in Senseonics by 6,694.1% during the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company's stock worth $3,203,000 after acquiring an additional 6,028,726 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Senseonics by 4.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,502,326 shares of the company's stock worth $2,298,000 after purchasing an additional 162,628 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new position in Senseonics during the fourth quarter worth $720,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.